(redirected from Air-Fluidized Bed Therapy)
AFBTAir Flow Back Technology
AFBTAir-Fluidized Bed Therapy (pressure-relief system)
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
[16] In the current economic environment, however, where an emphasis has been placed on moving patients from the high-cost hospital setting to less expensive settings, many clinicians and patients have sought to use air-fluidized bed therapy in the home.
One modality provided patients with air-fluidized bed therapy whenevevr they had 3rd or 4th stage sores, removing the therapy when the sores healed to 2nd stage or better; the other provided patients with conventional therapy as prescribed by their attending physicians.
Patients were excluded from the study if they were febrile or septic or otherwise required immediate hospitalization, since such patients would incur costs even before the air-fluidized bed therapy was provided.
In each of three major metropolitan areas, a nurse who was an expert at using air-fluidized bed therapy served as the study's home care coordinator (HCC).
For air-fluidized bed therapy patients, the HCCs conducted a home visit weekly for the first 4 weeks, and then biweekly for as long as the patient remained on the air-fluidized bed.
Virtually all patients in both the home air-fluidized bed therapy group and the control group had most or wet-to-dry dressings.
The model also assumed a charge of $70 for each day a patient was receiving air-fluidized bed therapy. This charge, identified by the manufacturer as its current price, covered the cost of the bed, the HCC's services, and any necessary equipment services.
It was assumed that Medicare would also pay for 80% of the $70-per-day charge for air-fluidized bed therapy.
The air-fluidized bed therapy group (n = 58) and the control group (n = 54) were very similar with regard to age, sex, education, principal payer, type of home support, reasons for immobility, and continence (Table 1); no differences were statistically significant.
Excluding patients in the "completely dropped" category, there were 47 patients in the group that received air-fluidized bed therapy and 50 patients in the control group who were receiving conventional therapy.
Air-fluidized bed therapy patients used the bed for an average of 116 days, or for 56% of the average available time (Table 3).
Table 4 is a summary of the costs of resource use in the air-fluidized bed therapy and control populations.